Anzeige
Mehr »
Montag, 29.06.2026 - Börsentäglich über 12.000 News
China kontrolliert Seltene Erden - Brasilien könnte die Antwort sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4YV | ISIN: CNE100000411 | Ticker-Symbol: XIN
Frankfurt
29.06.26 | 08:07
0,595 Euro
+5,31 % +0,030
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,6200,62523:00

Aktuelle News zur SHANDONG XINHUA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrSHANDONG XINHUA (00719): (I)POLL RESULTS OF THE ANNUAL GENERAL MEETING; AND (II)PAYMENT OF 2025 FINAL DIVIDEND-
FrSHANDONG XINHUA (00719): ARTICLES OF ASSOCIATION-
SHANDONG XINHUA PHARMACEUTICAL Aktie jetzt für 0€ handeln
FrSHANDONG XINHUA (00719): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025-
22.06.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON OBTAINING THE NOTICE OF APPROVAL FOR DRUG CLINICAL TRIALS-
01.06.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON OBTAINING THE DRUG REGISTRATION CERTIFICATE FOR SEVELAMER CARBONATE FOR SUSPENSION1
26.05.SHANDONG XINHUA (00719): REPLY SLIP FOR 2025 ANNUAL GENERAL MEETING-
26.05.SHANDONG XINHUA (00719): PROXY FORM FOR 2025 ANNUAL GENERAL MEETING-
26.05.SHANDONG XINHUA (00719): NOTICE OF THE ANNUAL GENERAL MEETING-
26.05.SHANDONG XINHUA (00719): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF THE ANNUAL GENERAL MEETING-
18.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON PHENOBARBITAL TABLETS HAVING PASSED THE GENERICS CONSISTENCY EVALUATION-
11.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON AMBROXOL HYDROCHLORIDE AND CLENBUTEROL HYDROCHLORIDE ORAL SOLUTION HAVING OBTAINED ...2
08.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON BENSERAZIDE HYDROCHLORIDE HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF MARKETING ...2
28.04.Shandong Xinhua Pharmaceutical Co. Ltd Q1 Income Falls-
28.04.SHANDONG XINHUA (00719): REMINDER LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
28.04.SHANDONG XINHUA (00719): REMINDER LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
28.04.SHANDONG XINHUA (00719): UNAUDITED FIRST QUARTER RESULTS OF 2026-
28.04.SHANDONG XINHUA (00719): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT-
28.04.SHANDONG XINHUA (00719): 2025 ANNUAL REPORT-
24.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT IN RELATION TO OBTAINING OF THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG ...1
15.04.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON BUMETANIDE INJECTION HAVING OBTAINED DRUG REGISTRATION CERTIFICATE1
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1